Literature DB >> 2448257

Polymorphonuclear leukocytes in the endometrium during the normal menstrual cycle.

C Poropatich1, M Rojas, S G Silverberg.   

Abstract

We investigated the presence of polymorphonuclear leukocytes (PMNs) in normal endometrium. Hematoxylin and eosin stained slides of 100 endometrial curettage and biopsy specimens were reviewed for dating and presence of PMNs. Polymorphonuclear leukocytes were quantitated by chloroacetate esterase (CAE) stains. Polymorphonuclear leukocytes were present in large numbers in areas of tissue degradation (day 28 and menstrual phase endometrium) and were found only in small numbers in intact tissue throughout the cycle. The CAE and H&E stains showed minimal difference in ability to detect PMNs. Polymorphonuclear leukocytes could be easily discriminated from endometrial granulocytes, which did not stain with CAE.

Entities:  

Mesh:

Year:  1987        PMID: 2448257     DOI: 10.1097/00004347-198709000-00004

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  10 in total

1.  Inhibition of human neutrophil degranulation by transforming growth factor-beta1.

Authors:  L Shen; J M Smith; Z Shen; M Eriksson; C Sentman; C R Wira
Journal:  Clin Exp Immunol       Date:  2007-04-02       Impact factor: 4.330

2.  Endometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection.

Authors:  Seth D Reighard; Richard L Sweet; Claudia Vicetti Miguel; Rodolfo D Vicetti Miguel; Mamatha Chivukula; Uma Krishnamurti; Thomas L Cherpes
Journal:  Am J Obstet Gynecol       Date:  2011-05-20       Impact factor: 8.661

3.  Endometrial histopathology in patients with laparoscopic proven salpingitis and HIV-1 infection.

Authors:  Nelly R Mugo; Julia Kiehlbauch; Nancy Kiviat; Rosemary Nguti; Joseph W Gichuhi; Walter E Stamm; Craig R Cohen
Journal:  Infect Dis Obstet Gynecol       Date:  2011-09-20

4.  Endometrial apoptosis and neutrophil infiltration during menstruation exhibits spatial and temporal dynamics that are recapitulated in a mouse model.

Authors:  Gregory M Armstrong; Jacqueline A Maybin; Alison A Murray; Moira Nicol; Catherine Walker; Philippa T K Saunders; Adriano G Rossi; Hilary O D Critchley
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 5.  Acupuncture for Primary Dysmenorrhea: A Potential Mechanism from an Anti-Inflammatory Perspective.

Authors:  Wen-Yan Yu; Liang-Xiao Ma; Zhou Zhang; Jie-Dan Mu; Tian-Yi Sun; Yuan Tian; Xu Qian; Yi-Dan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-03       Impact factor: 2.629

Review 6.  Innate immune defences in the human endometrium.

Authors:  Anne E King; Hilary O D Critchley; Rodney W Kelly
Journal:  Reprod Biol Endocrinol       Date:  2003-11-28       Impact factor: 5.211

7.  Selective CB2 up-regulation in women affected by endometrial inflammation.

Authors:  Teresa Iuvone; Daniele De Filippis; Attilio Di Spiezio Sardo; Alessandra D'Amico; Sara Simonetti; Stefania Sparice; Giuseppe Esposito; Giuseppe Bifulco; Luigi Insabato; Carmine Nappi; Maurizio Guida
Journal:  J Cell Mol Med       Date:  2008-04       Impact factor: 5.310

8.  Eotaxin levels in patients with primary dysmenorrhea.

Authors:  Evrim Gul; Ebru Celik Kavak
Journal:  J Pain Res       Date:  2018-03-23       Impact factor: 3.133

9.  Acupuncture Alleviates Menstrual Pain in Rat Model via Suppressing Eotaxin/CCR3 Axis to Weak EOS-MC Activation.

Authors:  Wen-Yan Yu; Liang-Xiao Ma; Yuan Tian; Jie-Dan Mu; Zhou Zhang; Tian-Yi Sun; Xu Qian; Jun-Xiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-13       Impact factor: 2.629

10.  Effects of controlled ovarian stimulation on vascular barrier and endothelial glycocalyx: a pilot study.

Authors:  Nikolai Hulde; N Rogenhofer; M Rehm; C Thaler; F Brettner; N C Eckert; I Fetz; J-I Buchheim; T Kammerer; A Dendorfer; A Choukèr; K F Hofmann-Kiefer
Journal:  J Assist Reprod Genet       Date:  2021-07-20       Impact factor: 3.412

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.